Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Celldex Therapeutics begins phase III trial of rindopepimut

Dec. 2, 2011

Curis and the Leukemia and Lymphoma Society agree to develop CUDC-907

Dec. 2, 2011

Novel caspase-3 activators and apoptosis inducers reported in patent literature

Dec. 2, 2011

Novel PI3K and mTOR inhibitors patented by Spanish researchers

Dec. 2, 2011

Costimulatory fusion protein enhances activity of tumor vaccine in vivo

Dec. 2, 2011

First-in-human results presented on PRS-050 in patients with advanced solid malignancies

Dec. 2, 2011

Idera Pharmaceuticals regains global rights to IMO-2055

Dec. 1, 2011

Merrimack Pharmaceuticals begins phase I study of MM-121 with multiple anticancer therapies

Dec. 1, 2011

Talon Therapeutics enrolls first patient in phase III Marqibo study

Dec. 1, 2011

Marina Biotech and Debiopharm select lead formulation for bladder cancer program

Dec. 1, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...